PARP Inhibitors: Breast Cancer’s Breakthrough and Resistance
In recent years, poly(ADP-ribose) polymerase inhibitors (PARPi) have revolutionized the landscape of cancer therapy, particularly in the management of breast ...
Tag: novel therapeutic strategies for breast cancer
CircKIAA1617 Enhances Stemness in ER-Positive Breast Cancer
In a groundbreaking study published in Molecular Cancer, researchers explored the role of CircKIAA1617 in the context of estrogen receptor-positive ...
Dual Inhibitors: Genistein and Apigenin Target Breast Cancer
Recent advancements in breast cancer research have shed light on the potential therapeutic applications of natural compounds, particularly those derived ...
New Alepterolic Acid Derivatives Target Breast Cancer
In a groundbreaking study, researchers have unveiled a new class of anticancer agents derived from alepterolic acid, specifically designed to ...
Gold Nanoparticles Deliver Chrysin to Triple-Negative Breast Cancer
In the rapidly evolving landscape of cancer therapeutics, the integration of nanotechnology with natural compounds has emerged as a beacon ...
CYPD Restricts HR+ Breast Cancer in Mice
In a groundbreaking study poised to redefine our understanding of hormone receptor-positive (HR⁺) breast cancer development, researchers have shed new ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!